 Home > Medical News > Latest Medical News > Roche IL-6 receptor inhibitor receives FDA emergency use authorization to treat severe COVID-19 hospitalized patients

Roche IL-6 receptor inhibitor receives FDA emergency use authorization to treat severe COVID-19 hospitalized patients

 Last Update: 2021-08-11
 Source: Internet
 Author: User

Tags

chief sustainability officer

angiotensin receptor antagonist

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 25, 2021, Roche announced that the US FDA granted its intravenous IL-6 receptor inhibitor Actemra/RoActemra (tocilizumab) emergency use authorization (EUA) for the treatment of adult patients hospitalized with COVID-19 And pediatric patients two years and older

There is an overactive immune response in patients with severe COVID-19

This EUA award is based on the positive results of 4 randomized controlled clinical trials, with a total of more than 5,500 patients enrolled, aiming to evaluate the efficacy and safety of tocilizumab treatment in COVID-19 hospitalized patients

In terms of safety, no new safety signals have been found in all studies.

Dr.

Reference materials:

[1] Roche's Actemra/RoActemra receives US FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.